- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03370081
Effects of Capnometry Monitoring in Post Anesthesia Care Unit (CAPNOSSPI)
Study Overview
Detailed Description
In France, there is actually no recommandation about capnography monitoring in recovery rooms. Nevertheless, some patients are still ventilated in post-anesthesia care units during awakening period. Alveolar hypoventilation could induce moderate hypercapnia, thereby stimulate central ventilatory command. However, this hypoventilation could delay the clearance of anesthetic gases. Capnometry monitoring could influence ventilation applied to these patients. Recovery rooms nurses would perform moderate hyperventilation in response to hign capnometry values. This method could enhance gases elimination, with faster spontaneous breathing recovery and extubation. Length of stay in recovery room could also be shortened. An objective surrogate of ventilation is maximal End Tidal CO2, if there is no alveolo-capillary gradient abnormality (Obesity, Chronic respiratory disease, Cyanogenic heart disease). Thus, this study will compare the percentage of patients who reached a maximum End Tidal CO2 greater than 45mmHg during awakening period in post-anesthesia care unit (PACU) in 2 groups :
- first group ("non-blind group") with capnography monitoring see by the PACU nurses
- second group ("blind group") with capnography monitoring but PACU nurses cannot see the values Other parameters like the time between ventilator's disconnection and the first ventilatory cycle in spontaneous ventilation, the time between ventilator's disconnection and tracheal extubation or laryngeal mask's withdrawal, the minimal SpO2 reached after tracheal extubation or laryngeal mask withdrawal or the length of stay in PACU are also recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33076
- Centre Hospitalier Universitaire De Bordeaux
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Major patients with given written consent
- General anesthesia, induction with Propofol infusion and Target-Controlled Infusion (TCI) remifentanil, relayed with inhaled sevoflurane and TCI remifentanil
- Upper airway control with naso-orotracheal tube or laryngeal mask
- Ventilated normotherm patients in PACU
Exclusion Criteria:
- Minor or pregnant patients
- Obesity with Body Mass Index > 40 kg/m²
- Chronic respiratory disease with SpO2<90% in ambiant air
- Cyanogenic heart disease
- Patients under myorelaxant in PACU
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CAPNO+
END TIDAL CO2(EtCO2) is monitoring and PACU nurses can see the values delivered by the capnography device
|
MONITORING OF CAPNOMETRY USING ETCO2 METHOD
|
|
No Intervention: CAPNO-
END TIDAL CO2(EtCO2) is monitoring but PACU nurses cannot see the values delivered by the capnography device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
End Tidal CO2 up
Time Frame: through awakening period in PACU, an average of 30 minutes
|
Percentage of patients who reached a maximum End Tidal CO2 greater than 45mmHg during awakening period in post-anesthesia care unit (PACU)
|
through awakening period in PACU, an average of 30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
End Tidal CO2 max 1
Time Frame: through awakening period in PACU, an average of 15 minutes
|
Maximum EtCO2 reached before the first ventilatory cycle in spontaneaous ventilation
|
through awakening period in PACU, an average of 15 minutes
|
|
End Tidal CO2 max 2
Time Frame: through awakening period in PACU, an average of 30 minutes
|
Maximum EtCO2 reached after the first ventilatory cycle in spontaneous ventilation
|
through awakening period in PACU, an average of 30 minutes
|
|
respiratory rate
Time Frame: through awakening period in PACU, an average of 15 minutes
|
Respiratory rate applied by PACU nurse before the first ventilatory cycle in spontaneous ventilation
|
through awakening period in PACU, an average of 15 minutes
|
|
spontaneous ventilation time
Time Frame: through awakening period in PACU, an average of 15 minutes
|
Time (in minutes) between ventilator's disconnection and the first ventilatory cycle in spontaneous ventilation
|
through awakening period in PACU, an average of 15 minutes
|
|
time for removal of airway device
Time Frame: through awakening period in PACU, an average of 30 minutes
|
Time (in minutes) between ventilator's disconnection and tracheal extubation or laryngeal mask's withdrawal
|
through awakening period in PACU, an average of 30 minutes
|
|
Spo2 min
Time Frame: through awakening period in PACU, an average of 2 hours
|
Minimal SpO2 after tracheal extubation or laryngeal mask withdrawal
|
through awakening period in PACU, an average of 2 hours
|
|
length of stay in PACU
Time Frame: through awakening period in PACU, an average of 2 hours
|
Length of stay in PACU in minutes
|
through awakening period in PACU, an average of 2 hours
|
|
time for oxygenotherapy removal
Time Frame: through awakening period in PACU, an average of 1 hour
|
Time (in minutes) between tracheal extubation or laryngeal mask withdrawal and oxygenotherapy weaning
|
through awakening period in PACU, an average of 1 hour
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CHUBX2017/18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Capnography
-
Minia UniversityNot yet recruiting
-
Hadassah Medical OrganizationCovidien Inc.UnknownSedation | CapnographyIsrael
-
Medtronic - MITGCompleted
-
Bursa Uludag UniversitesiActive, not recruitingEndobronchial Ultrasound | CapnographyTurkey
-
University of Mississippi Medical CenterCompletedPulmonary Ventilation | CapnographyUnited States
-
Chinese University of Hong KongHospital Authority, Hong KongRecruitingNasogastric Tube | Diagnostic Accuracy | CapnographyChina
-
University Hospital, AngersUnknownIdentification of Risk Factors for Alteration of the Cellular-arterial Gradient of CO2 (DELTA-CAPNO)Mechanical Ventilation | Prehospital Capnography MonitoringFrance
-
Tribhuvan University, NepalCompletedIntubation | Ultrasound Imaging | Capnography
-
University of UtahCompletedClinical Interpretation of Capnography Waveforms
-
Hopital of MelunCompletedMechanical Ventilation | Prone Position | Volumetric CapnographyFrance
Clinical Trials on CAPNOGRAPHY
-
Yale UniversityThrasher Research FundCompleted
-
Lahey ClinicTerminatedChronic Obstructive Pulmonary Disease | Asthma | Interstitial Lung DiseaseUnited States
-
Technical University of MunichCompletedApnea | Complications | HypoxemiaGermany
-
Minia UniversityNot yet recruiting
-
Chinese University of Hong KongHospital Authority, Hong KongRecruitingNasogastric Tube | Diagnostic Accuracy | CapnographyChina
-
Akdeniz UniversityCeren KahramanCompletedDiabetic Ketoacidosis | Brain Edema | Metabolic AcidosisTurkey
-
University of GiessenEnrolling by invitationVascular Diseases | Lung Diseases | Hypertension, Pulmonary | Chronic Thromboembolic Pulmonary Hypertension | Hypertension;Pulmonary;PrimaryGermany
-
Rutgers, The State University of New JerseyTerminated
-
Bursa Uludag UniversitesiActive, not recruitingEndobronchial Ultrasound | CapnographyTurkey
-
Mashhad University of Medical SciencesCompletedCardiopulmonary ArrestIran, Islamic Republic of